Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Skull Base Surgery
|
January 1, 1994
Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation
L B Harrison, D G Pfister, D Kraus, et al.
Head & Neck
|
September 1, 1996
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer
M J Zelefsky, D H Kraus, D G Pfister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2002
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma
R J Wong, D T Lin, H Schöder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study
D F Bajorin, M F Sarosdy, D G Pfister, et al.
Head & Neck
|
May 1, 1997
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
L B Harrison, M J Zelefsky, D G Pfister, et al.
Journal of the National Cancer Institute
|
March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies
R J Motzer, E Rodriguez, V E Reuter, et al.
Cancer
|
March 10, 2001
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma
E J Sherman, D G Pfister, H S Ruchlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
L A Dunn, M G Fury, H Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel
B E Hillner, J N Ingle, J R Berenson, et al.
Oncology (Williston Park, N.Y.)
|
August 12, 1998
NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network
A Forastiere, H Goepfert, D Goffinet, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Skull Base Surgery
|
January 1, 1994
Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation
L B Harrison, D G Pfister, D Kraus, et al.
Head & Neck
|
September 1, 1996
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer
M J Zelefsky, D H Kraus, D G Pfister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2002
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma
R J Wong, D T Lin, H Schöder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study
D F Bajorin, M F Sarosdy, D G Pfister, et al.
Head & Neck
|
May 1, 1997
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
L B Harrison, M J Zelefsky, D G Pfister, et al.
Journal of the National Cancer Institute
|
March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies
R J Motzer, E Rodriguez, V E Reuter, et al.
Cancer
|
March 10, 2001
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma
E J Sherman, D G Pfister, H S Ruchlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
L A Dunn, M G Fury, H Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel
B E Hillner, J N Ingle, J R Berenson, et al.
Oncology (Williston Park, N.Y.)
|
August 12, 1998
NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network
A Forastiere, H Goepfert, D Goffinet, et al.
Page
of 6